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The progressive loss of muscle strength during aging
isa commondegenerativeevent of unclearpathogen-
esis. Although muscle functional decline precedes
age-related changes in other tissues, its contribution
to systemic aging is unknown. Here, we show that
muscle aging is characterized in Drosophila by the
progressive accumulation of protein aggregates
that associate with impaired muscle function. The
transcription factor FOXO and its target 4E-BP re-
move damaged proteins at least in part via the
autophagy/lysosome system, whereas foxo mutants
have dysfunctional proteostasis. Both FOXO and
4E-BP delay muscle functional decay and extend life
span. Moreover, FOXO/4E-BP signaling in muscles
decreases feeding behavior and the release of insulin
from producing cells, which in turn delays the age-
related accumulation of protein aggregates in other
tissues. These findings reveal an organism-wide
regulation of proteostasis in response to muscle
aging and a key role of FOXO/4E-BP signaling in the
coordination of organismal and tissue aging.
INTRODUCTION
Aging of multicellular organisms involves distinct pathogenic
events that include higher mortality, the progressive loss of
organ function, and susceptibility to degenerative diseases,
some of which arise from protein misfolding and aggregation.
Recent genetic studies in the mouse, the nematode Caenorhab-
ditis elegans, and the fruitfly Drosophila melanogaster have
expanded our understanding of the evolutionarily conserved
signaling pathways regulating aging, with the identification of
several mutants that have prolonged or shortened life spans
(Kenyon, 2005). Manipulation of longevity-regulating pathways
in certain tissues is sufficient to extend life expectancy, indi-
cating that some tissues have a predominant role in life span
extension (Libina et al., 2003; Wang et al., 2005; Wolkow et al.,
2000). For example, foxo overexpression in the Drosophila fatbody extends life span, indicating a key role of this tissue in
the regulation of longevity (Giannakou et al., 2004; Hwangbo
et al., 2004). In addition, because most tissues undergo progres-
sive deterioration during aging (Garigan et al., 2002), it is thought
that organismal life span may be linked to tissue senescence.
However, our understanding of the mechanisms regulating
tissue aging and their interconnection to life span is limited. For
example, analysis in Drosophila has revealed that the prevention
of age-dependent changes in cardiac performance does not
alter life span (Wessells et al., 2004), raising the possibility that
functional decline in distinct tissues may have different
outcomes on the systemic regulation of aging.
The Insulin/IGF-1 signaling pathway has been implicated in the
control of aging across evolution via its downstream signaling
component FOXO (DAF-16 in C. elegans), a member of the
fork-head box O transcription factor family (Salih and Brunet,
2008). FOXO regulates the expression of a series of target genes
involved in metabolism, cell growth, cell proliferation, stress
resistance, and differentiation via direct binding to target gene
promoter regions (Salih and Brunet, 2008). Mutations in foxo/
daf-16 reduce life span and stress resistance in both C. elegans
and flies, indicating a key role in organism aging (Junger et al.,
2003; Salih and Brunet, 2008). In addition to regulating life
span, FOXO has been reported to prevent the pathogenesis of
some age-related diseases. For example, FOXO reduces the
toxicity associated with aggregation-prone human mutant
Alzheimer’s and Huntington’s disease proteins (proteotoxicity)
in C. elegans and mice, suggesting that regulating protein
homeostasis (proteostasis) during aging may have a direct effect
on the pathogenesis of human neurodegenerative diseases
(Cohen et al., 2006; Hsu et al., 2003; Morley et al., 2002).
However, little is known on the protective mechanisms induced
in response to FOXO signaling and whether they vary in different
aging tissues and disease contexts.
Among the plethora of age-related pathological conditions,
the gradual decay in muscle strength is one of the first hallmarks
of aging in many organisms, including Drosophila, C. elegans,
mice and, importantly, humans (Augustin and Partridge, 2009;
Herndon et al., 2002; Nair, 2005; Zheng et al., 2005). However,
despite its medical relevance, the mechanisms underlying
muscle aging are incompletely understood. Functional changes
in skeletal muscles temporally precede the manifestation ofCell 143, 813–825, November 24, 2010 ª2010 Elsevier Inc. 813
Figure 1. FOXO Signaling in Skeletal Muscles Preserves Proteostasis during Aging
(A–D) Electron micrographs of immunogold-labeled Drosophila skeletal muscles of wild-type flies at one (A and B) and 5 weeks of age (C and D). Protein
aggregates (PA) are detected in the cytoplasm in proximity to mitochondria (Mt) and myofibrils (Myof) in old (C and D) but not young flies (A and B). Numerous
gold particles (indicative of anti-ubiquitin immunoreactivity) localize to filamentous structures at 5 weeks of age (C and D), while only a few are present in muscles
from young flies. Scale bars are 1 mm (A and C) and 500 nm (B and D).
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aging in other tissues (Herndon et al., 2002), and reducedmuscle
strength is associated with an increased risk in developing
Alzheimer’s and Parkinson’s diseases (Boyle et al., 2009; Chen
et al., 2005). However, although aging-related changes in
skeletal muscles have been proposed to affect physiological
processes in distal organs (Nair, 2005), whether or not muscle
senescencemodulates the pathogenesis of degenerative events
in other tissues is unknown.
The fruit fly Drosophila is an excellent model to study muscle
aging. The progressive decline in muscle strength and function
observed in humans is recapitulated in this system (Rhodenizer
et al., 2008), which is amenable to extensive genetic manipula-
tion. By using this model organism, we have searched for the
molecular mechanisms responsible for muscle aging and
found that decreased protein quality control plays a role in the
pathogenesis of age-related muscle weakness. Interestingly,
increased activity of the transcription factor FOXO and its target
Thor/4E-BP are sufficient to delay this process and preserve
muscle function at least in part by promoting the basal activity
of the autophagy/lysosome system, an intracellular protein
degradation pathway that removes damaged protein aggregates
(Rubinsztein, 2006).
Moreover, we report that FOXO/4E-BP signaling in muscles
extends life span and regulates proteostasis organism-wide by
regulating feeding behavior, release of insulin from producing
cells, and 4E-BP induction in nonmuscle tissues. Thus, we
propose a model by which FOXO/4E-BP signaling in muscles
preserves systemic proteostasis by mimicking some of the
protective effects of decreased nutrient intake.
RESULTS
Loss of Proteostasis during Muscle Aging
Is Prevented by FOXO
To detect cellular processes that are responsible for decreased
muscle strength in aging flies, we monitored cellular changes in
indirect flight muscles of wild-type flies by immunogold-electron
microscopy (IEM). In older flies, we detected filamentous cyto-
plasmic structures that were instead absent in muscles from
young flies (Figures 1A–1D). Filamentous materials present in
these structures stained with an anti-ubiquitin antibody (Fig-
ure 1D), a marker for proteins that are polyubiquitinated, sug-
gesting that the cytoplasmic structures are aggregates of
damaged proteins. Aggregates were variable in size and were
detected in both resin-embedded sections (Figure 1) and cryo-
sections (data not shown) of thoracic muscles of the old but
not the young flies, in parallel with an increase in the overall(E) The number of gold particles, indicative of ubiquitin immunoreactivity, significa
**p < 0.01).
(F–L) Immunostaining of indirect flight muscles from flies with (UAS-foxo/+;Mhc-
5 weeks of age (I and J), and foxo homozygous null (MhcGal4, foxo21/25) flies (H
an increased deposition of aggregates containing polyubiquitinated proteins duri
overexpressing foxo (G and J). Conversely, muscles from foxo null animals displa
controls (F and I). Note the significant increase in the cumulative area of protein agg
versus (J), indicating that the control of protein homeostasis is linked to FOXO ac
0.01). Representative polyubiquitin and Ref(2)P immunoreactivities are shown in in
myofibrils. Scale bar is 20 mm (F–K).
See also Figure S1, Figure S2, and Figure S3.number of gold particles (Figure 1E). To test the hypothesis
that muscle function during aging may decrease due to defects
in protein homeostasis, we better characterized the age-related
deposition of protein aggregates by immunofluorescence. In
agreement with the IEM analysis (Figures 1A–1E), we observed
that aging skeletal muscles progressively accumulate aggre-
gates of polyubiquitinated proteins (ranging up to several mm)
that colocalize with p62/Ref(2)P, an inclusion body component
(Figures 1F and1I). The cumulative area of protein aggregates
increases during aging (Figure 1L), suggesting that the progres-
sive protein damage, together with a decrease in the turnover of
muscle proteins, may result in the age-related decline of muscle
strength.
To better characterize how protein quality control is linkedwith
aging in muscles, we analyzed the deposition of protein
aggregates in syngenic flies with foxo overexpression. Foxo
overexpression results in its activation (Giannakou et al., 2004;
Hwangbo et al., 2004) and was achieved specifically in muscles
via the UAS-Gal4 system using the Mhc-Gal4 driver (see Fig-
ure S1 available online). Increased FOXO activity in muscles
did not affect developmental growth and differentiation (as esti-
mated by bodyweight and sarcomere assembly) (Figure S2), and
resulted in the delayed accumulation of aggregates containing
polyubiquitinated proteins and Ref(2)P during aging (Figures 1G
and 1J, compare with control muscles in Figures 1F and 1I).
Next, we tested whether foxo null animals display accelerated
muscle aging, and found an increased accumulation of protein
aggregates (Figures 1H and1K), indicating that FOXO is both
necessary and sufficient to modulate muscle proteostasis
(Figure 1L).
To further corroborate these findings, we overexpressed
either the wild-type or the constitutive-active foxo transgenes
using the Dmef2-Gal4 muscle driver in combination with the
temperature-sensitive tubulin-Gal80ts transgene to achieve
adult-onset foxo overexpression in muscles (Figure S3). Trans-
gene overexpression significantly preserved muscle proteosta-
sis in both cases, while the controls displayed an increased
accumulation of protein aggregates (Figure S3). All together,
these results indicate that protein homeostasis depends on
FOXO activity during muscle aging.
4E-BP Controls Proteostasis in Response
to Pten/FOXO Activity
To dissect the stimuli that encroach on FOXO to control proteo-
stasis, we tested whether Pten overexpression phenocopies
FOXO activation. Consistent with its role in activating FOXO,
we found that Pten decreased the accumulation of proteinntly increases in old age (standard error of the mean [SEM] is indicated with n;
Gal4/+) or without (Mhc-Gal4/+) foxo overexpression at 1 week (F and G) and
and K). Polyubiquitin (red) and p62/Ref(2)P (green) immunoreactivities reveal
ng aging in muscles of control flies (F and I), and, to a lesser extent, in muscles
y an accelerated deposition of protein aggregates (H and K) in comparison with
regates (indicative of both aggregate size and number) in (K) versus (I), and in (I)
tivity in muscles (quantification in [L]) (SEM is indicated with n; *p < 0.05, **p <
sets. Phalloidin staining (blue) outlines F-actin, which is a component ofmuscle
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Figure 2. 4E-BP Preserves Proteostasis in Response to Pten/FOXO Signaling
(A–F) Immunostaining of muscles overexpressing Pten and constitutive active (CA) 4E-BP. In both cases, a decrease in the accumulation of polyubiquitin protein
aggregates is observed at 5 weeks of age in comparison with age-matched controls, suggesting that these interventions can preserve proteostasis in aging
muscles. Scale bar is 20 mm. Hsp70 overexpression has instead limited effects (Figure S4, Table S1, Table S2).
(G) A reduction in the cumulative area of protein aggregates is observed upon increased activity of either Pten or 4E-BP in comparison with controls (SEM is
indicated with n; **p < 0.01, ***p < 0.001).
(H) Relative quantification of Thor/4E-BP mRNA levels from thoraces of syngenic flies at 1 and 5 weeks of age. A significant increase in 4E-BP expression is
detected in response to fasting and Pten and FOXO activity (**p < 0.01, ***p < 0.001; SEM is indicated with n = 4).aggregates during aging (Figures 2B and 2E; see controls in
Figures 2A and 2D).
Next, we examined the responses induced by Pten/FOXO
signaling. First, we examined whether FOXO activity delays
protein damage by inducing chaperones that are key for protein
quality control (Tower, 2009). In response to FOXO activity in
muscles, we detected an increase in the mRNA levels of
Hsp70 and its cofactors involved in protein folding (Hip, Hop,
Hsp40, and Hsp90) but not in protein degradation (Chip and
Chap) (Figure S4 and Table S1). FOXO regulates directly the816 Cell 143, 813–825, November 24, 2010 ª2010 Elsevier Inc.expression of Hsp70 and its cofactors, as estimated with Lucif-
erase transcriptional reporters based on the proximal promoter
region of target genes (Figure S4 and Table S2). On this basis,
we tested whether Hsp70 overexpression preserves proteosta-
sis during aging but found little changes in the age-related accu-
mulation of protein aggregates (Figure S4). Thus, we conclude
that additional FOXO-dependent responses are involved.
Among the FOXO-target genes, Thor/4E-BP has a key role
in delaying aging by regulating protein translation (Zid et al.,
2009; Tain et al., 2009). However, the cellular mechanisms that
are regulated by 4E-BP are largely unknown. To test whether
4E-BP controls proteostasis during muscle aging, we overex-
pressed a constitutive active form of 4E-BP in muscles and
observed limited accumulation of protein aggregates during
aging (Figures 2C and 2F) compared with controls (Figures 2A
and 2D). All together, increased activity of Pten or 4E-BP sig-
nificantly decreases the cumulative area of protein aggregates
(Figure 2G).
In addition, a significant increase in 4E-BP mRNA levels is
induced in muscles upon Pten, foxo overexpression, and fasting
(Figure 2H). All together, these findings suggest that 4E-BP is key
to control proteostasis in response to Pten/FOXO signaling.
FOXO/4E-BP Signaling Regulates Proteostasis via
the Autophagy/Lysosome System
While FOXO/4E-BP signaling mounts a stress resistance
response that may decrease the extent of protein damage due
to various stressors (Salih and Brunet, 2008; Tain et al., 2009),
we wondered whether it regulates the removal of damaged
proteins via macroautophagy. In this process, entire regions of
the cytoplasm are sequestered in a double membrane vesicle
(autophagosome) that subsequently fuses with a lysosome,
where the autophagic cargo is degraded (Rubinsztein, 2006).
Although the primary role of autophagy is to mount an adaptive
response to nutrient deprivation, its basal activity is required
for normal protein turnover (Hara et al., 2006). In agreement
with this notion, suppression of basal autophagy leads to the
accumulation of polyubiquitin protein aggregates in a number
of contexts (Korolchuk et al., 2009; Rubinsztein, 2006).
To test whether autophagy is regulated in response to FOXO
signaling in muscles, we used a GFP-tagged version of the
autophagosome marker Atg5 (Rusten et al., 2004). While the
number of Atg5-GFP punctae decreases during aging in control
muscles (Figures 3A and 3B), it is in part maintained in response
to foxo overexpression (Figures 3C and 3D, and quantification in
Figure 3E). In addition, given the interconnection between
the lysosome system and autophagy, we monitored a GFP-
tagged version of the lysosome marker Lamp1 (lysosome-asso-
ciated membrane protein 1) and detected an overall increase in
the number of GFP punctae in response to overexpression of the
autophagy inducer kinase Atg1, foxo, and 4E-BP CA in muscles
at both 1 and 5 weeks of age (Figures 3G–3I and 3K–3M in
comparison with controls in Figures 3F and 3J and quantification
in Figure 3N).
Closer inspection revealed that the abundance of Lamp1-GFP
vesicles inversely correlates with the progressive deposition of
polyubiquitin protein aggregates, suggesting that FOXO/4E-BP
signaling regulates proteostasis at least in part via the
autophagy/lysosome system. To further test this hypothesis,
we analyzed the age-related changes in autophagy gene expres-
sion, which have been previously used as a correlative measure-
ment of autophagic activity (Gorski et al., 2003; Simonsen et al.,
2008). Interestingly, the expression of several autophagy genes
involved in autophagosome induction (Atg1), nucleation (Atg6),
and elongation (Atg5, Atg7, and Atg8) progressively declines
during aging in muscles (Figure 3O), suggesting that gene
expression changes likely contribute to the accumulation of
damaged proteins. Conversely, foxo overexpression increasedthe basal expression of several Atg genes at both young and
old age, suggesting that their increased expression contributes
to the beneficial effects of FOXO on proteostasis. To test this
hypothesis, we knocked down Atg7 levels in foxo-overexpress-
ing flies and analyzed the deposition of polyuiquitinated protein
aggregates. Interestingly, RNAi treatment brought about a
50% decrease in Atg7 mRNA levels and resulted in a partial
increase in the buildup of insoluble ubiquitinated proteins at
8 weeks, compared with age-matched, mock-treated flies
(white RNAi) and 1-week-old flies (Figure 3P).
All together, these findings suggest that FOXO/4E-BP
signaling prevents the buildup in protein damage, at least in
part by promoting the basal activity of the autophagy/lysosome
system.
Prevention of Muscle Aging by FOXO and 4E-BP
Extends Life Span
To evaluate whether preserving proteostasis can prevent
functional alterations in aging muscles, we assessed muscle
strength with negative geotaxis and flight assays (see Experi-
mental Procedures). As shown in Figures 4A and 4B, muscle
functionality gradually decreases in aging flies, resulting in
impaired climbing and flight ability. Notably, foxo (Figure 4A)
and 4E-BP activity (Figure 4B) significantly preserve muscle
strength during aging. Thus, FOXO and 4E-BP prevent both
the cellular degenerative events and the functional decay of
aging muscles.
Epidemiological studies in humans have associated muscle
senescence with increased mortality (Nair, 2005), implying that
muscle aging may have organism-wide consequences beyond
muscle function. To ask whether the prevention of muscle aging
affects the organism life span, we manipulated the activity of
components of the Akt pathway in muscles and scored for their
effects on viability. As shown in Figures 4C and 4D, either Pten,
foxo, or 4E-BP CA overexpression in muscles is sufficient to
significantly extend longevity by increasing the median and
maximum life span. 4E-BP increased life span also in foxo
heterozygous null animals (Figure 4D), while Hsp70 overexpres-
sion on the other hand showed little effects (Figure S5). All
together, these findings indicate that the extent of muscle aging
is interconnected with the life span of the organism.
FOXO/4E-BP Signaling in Muscles Influences
Feeding Behavior and the Release of Insulin
from Producing Cells
Considering that both fasting and FOXO induce 4E-BP expres-
sion (Figure 2H), we wondered whether the systemic effect of
FOXO signaling on life span extension can result, at least in
part, from reduced food intake.
To test this hypothesis, we examined whether feeding
behavior would be decreased in adults with FOXO and 4E-BP
activation in muscles. We first monitored the amount of
liquid food ingested using the CAFE´ assay (capillary feeding)
(Ja et al., 2007). Interestingly, feeding was decreased in
response to FOXO/4E-BP signaling in muscles (Figure 5A). To
substantiate this finding, we measured the ingestion of blue-
colored food (Xu et al., 2008) and detected significant differ-
ences in food intake with this assay (Figure 5B), confirmingCell 143, 813–825, November 24, 2010 ª2010 Elsevier Inc. 817
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Figure 4. FOXO/4E-BP Signaling Preserves Muscle Function and Extends Life Span
(A) Muscle function gradually decreases during aging as indicated by an increase in the percentage of flies with climbing and flight defects. However, foxo
preserves their function in comparison with controls (flight ability: n[flies] = 10 (week 1 and 5) and 30 (week 8) with n[batch] = 3 (week 1 and 5) and 2 (week 8);
standard deviation (SD) is indicated and *p < 0.05. Climbing ability: (n[Mhc-Gal4/+] = 1264, n[Mhc-Gal4/UAS-foxo] = 966, with n indicating the number of flies
at day 1; p < 0.001).
(B) Similar to FOXO, 4E-BP activity also results in decreased age-related flight and climbing deficits in comparisonwith controls (flight ability: n[flies]R 10 (week 1
and 5) and 25 (week 8) with n[batch]R 3 (week 1 and 5) and 2 (week 8); SD is indicated and *p < 0.05. Climbing ability: (n[Mhc-Gal4/+] = 204, n[Mhc-Gal4/UAS-4E-
BP CA] = 403, p < 0.001).
(C) Survival of flies during aging. Foxo overexpression in muscles significantly extends the median and maximum life span (median and maximum life span:
Mhc-Gal4/+ = 61 and 82 days (n = 1264); UAS-foxo tr.#1/+;Mhc-Gal4/+ = 73 and 100 days (n = 1184); Mhc-Gal4/UAS-foxo tr.#2 = 76 and 94 days
(n = 966); p < 0.001).
(D) Life span of flies with increased Pten and 4E-BP activity in muscles is extended in comparison with matched controls (median and maximum life span of
4E-BP: Mhc-Gal4/+ = 63 and 78 days (n = 204); Mhc-Gal4/UAS-4E-BP CA = 71 and 84 days (n = 403); Pten: Mhc-Gal4/+ = 55 and 76 days (n = 162);
Mhc-Gal4/UAS-Pten = 66 and 88 days (n = 130); p < 0.001). Similar increase in life span is brought about by 4E-BP CA overexpression in foxo21 heterozygous
null flies.
See also Figure S5 and Figure S7.that feeding behavior is affected. Next, to assess whether
decreased feeding behavior arises from developmental defects,
we measured the body weight of adult flies, which is a sensitive
indicator of developmental feeding (Demontis and Perrimon,
2009), but found no significant differences (Figure 5C). Thus,Figure 3. FOXO and 4E-BP Regulate Proteostasis at Least in Part via t
(A–E) Immunostaining of muscles expressing the marker of autophagosomes At
1 and 5 weeks of age upon foxo overexpression (C and D) in comparison with co
(F–N) Immunostaining of muscles expressing the lysosomal marker Lamp1-GFP
number of lysosomes (N) at both 1 (G-I) and 5 weeks of age (K–M), which invers
muscles (F and J). Scale bar is 10 mm (A–D and F-–M). In (N), SEM is indicated w
(O) RelativemRNA levels of autophagy genes from thoraces of 1- and 5-week-old fl
persists in response to FOXO. SEM is indicated with n = 4; *p < 0.05, **p < 0.01
(P) RNAi treatment against Atg7 results in a 50% knockdown of its mRNA levels
the increased detection of ubiquitin-conjugated proteins in Triton X-100 insoluble f
young flies (1 week old, black). Normalized values based on a-tubulin levels arethe behavior of flies overexpressing foxo and 4E-BP CA in
muscles most likely is not caused by developmental defects.
To assess the metabolic status, we monitored the glucose
concentration (glycemia) in the hemolymph. Similar to wild-
type flies starved for 24 hr, we detected a significant decreasehe Autophagy/Lysosome System
g5-GFP reveals a significant increase in their number (E) and maintenance at
ntrols (A and B). In (E), SEM is indicated with n; *p < 0.05 and **p < 0.01.
and overexpressing either Atg1, foxo, or 4E-BP CA. Note an increase in the
ely correlates with polyubiquitin immunoreactivity in comparison with control
ith n; *p < 0.05 and ***p < 0.001.
ies decrease during normal muscle aging, while their expression increases and
and ***p < 0.001.
in muscles and partially impairs FOXO-mediated proteostasis, as indicated by
ractions at 8weeks (old, red) in comparisonwithmock-treated (white RNAi) and
indicated.
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Figure 5. FOXO Signaling in Muscles Partially
Mimics Systemic Metabolic Changes Associated
with Fasting by Modulating Feeding Behavior
(A–C) Flies in which FOXO/4E-BP activity has been altered
specifically in muscles consume less food than matched
controls. Food consumption was determined via capillary
feeding CAFE´ assay over 2 hr periods (A), and by moni-
toring the ingestion of blue colored food in 24 hr (B). Error
bars represent SEM with n[measurements] = 44, 46, 52,
37, 103, and 61 in (A) and n = 2 in (B), with *p < 0.05,
**p < 0.01, ***p < 0.001. Decreased feeding does not result
from developmental defects, as indicated by similar body
weights of flies analyzed (C) (error bars represent SD with
nR 3).
(D) Relative glucose levels (glycemia) in the hemolymph of
flies overexpressing either foxo or 4E-BP CA in muscles,
and matched controls. Manipulation of FOXO/4E-BP
signaling in muscles brings about a reduction of glycemia
similar in part to that of wild-type flies starved for 24 hr, as
estimated with the glucose hexokinase assay (SEM is
indicated with n = 5, and **p < 0.01, ***p < 0.001).
(E–H) Immunostaining of Dilp-producing median neurose-
cretory cells in the brain of starved wild-type flies, flies
overexpressing foxo in muscles, and controls. Increase
in the immunoreactivity of the insulin-like peptide Dilp2
(green) is detected in producing cells in response to either
starvation (F) or foxo overexpression in muscles (H), in
comparison respectively with fed wild-type flies (E) and
controls with no foxo overexpression in muscles (G).
Smaller changes in Dilp5 levels are observed. Phalloidin
staining (blue) detects F-actin (scale bar is 20 mm; images
in [E]–[H] have the same magnification).
(I) Quantification of the intensity of staining indicates
that differences in Dilp2 fluorescence are significant
(SD is indicated with n[measurements] = 35, 69, 37, and
96 from n[brains] = 2, 4, 3, and 4; *p < 0.05).
(J–L) Quantification and immunostaining of adipose tissue
(peripheral fat body of the abdomen) from 2 week old flies.
(J) Note a significant increase in nuclear b-galactosidase
immunoreactivity (red) in the adipose tissue from flies
with a nuclear 4E-BP-lacZ reporter and foxo overexpres-
sion in muscles (L) in comparison with controls (K). F-actin
(green) and DAPI staining (indicative of nuclei, blue) are
shown. Scale bar is 20 mm. In (J), SEM is indicated with
n = 20 and ***p < 0.001.of glycemia in flies with FOXO and 4E-BP activation in muscles
(Figure 5D). All together, these findings suggest that FOXO and
4E-BP act as a metabolic brake in muscles that, by influencing820 Cell 143, 813–825, November 24, 2010 ª2010 Elsevier Inc.feeding behavior, mimic at least in part the
physiological changes that are associated with
fasting.
To gainmechanistic insights into the systemic
regulation of aging by FOXO/4E-BP signaling
in muscles, we next monitored the release of
insulin-like peptides (Dilps) from the Dilp-
producing median neurosecretory cells in the
brain, which have been previously shown to
mediate the response of life span to nutrition
in Drosophila (Broughton et al., 2010). We
detected a significant accumulation of the
insulin-like peptide Dilp2 (and to a lesser extent,Dilp5) in starved wild-type flies in comparison with fed flies
(Figures 5E and 5F). Increased immunoreactivity indicates
decreased release of Dilps and has been previously shown to
occur in response to starvation (Geminard et al., 2009). Next, we
tested whether similar changes would occur upon FOXO
signaling in muscles and found a partial accumulation of Dilps
(Figures 5G–5I).
Assuming that decreased Dilps secretion may result in
systemic FOXO activation, we monitored its activity using a
nuclear 4E-BP-lacZ transcriptional reporter. By immunostaining
adipose tissues with anti-b-galactosidase antibodies, we
detected higher 4E-BP expression upon foxo activation in
muscles in comparison with controls (Figures 5J–5L). Thus,
FOXO signaling in muscles appears to systemically activate
4E-BP expression in other tissues by regulating food intake
and insulin release.
FOXO/4E-BP Signaling in Muscles Regulates
Proteostasis in Other Aging Tissues
Our demonstration that FOXO/4E-BP signaling in muscles
extends life span in Drosophila and induces a systemic fasting-
like response, along with the observation that muscles undergo
age-related structural and functional changes precociously in
comparison with other tissues (Herndon et al., 2002; Zheng
et al., 2005), raises the possibility that muscle senescence may
influence the progression of age-related degenerative events in
the entire organism.
To test this hypothesis, we examined whether, in addition to
life span extension, FOXO signaling in muscles can affect protein
homeostasis in other tissues. As in the case of muscles (Figure 1
and Figure 2), we found that Ref(2)P/polyubiquitin aggregates
progressively accumulate in aging retinas (Figures 6A and 6D),
brains (Figures 6B and 6E), and adipose tissue (Figures 6C and
6F) (peripheral fat body of the abdomen). However, foxo overex-
pression in muscle resulted in decreased accumulation of
protein aggregates in other aging tissues (Figures 6D–6F; quan-
tification in Figure 6G). Similar changes were observed in
response to 4E-BP activity in muscles in comparison with
syngenic controls (Figure 6H). Importantly, this regulation is
muscle nonautonomous, as Mhc-Gal4 drives transgene expres-
sion only in muscles (and not in the retina, brain or adipose
tissue) (Figure S1). To further test the finding that FOXO/4E-BP
signaling in muscles delays the systemic impairment of proteo-
stasis in other tissues (Figures 6A–6H), we analyzed by western
blot the ubiquitin levels of Triton X-100 insoluble fractions, which
included protein aggregates, from either thoraces (which mainly
consist of foxo-overexpressing muscles) or heads and abdo-
mens (which are enriched in nonmuscle tissues and muscles
with little foxo overexpression) (Figure S1), at 1 and 8 weeks of
age. In agreement with the increased deposition of protein
aggregates observed during aging by immunofluorescence
(Figure 1, Figure 2, and Figures 6A–6F), ubiquitin levels were
dramatically increased in the Triton X-100 insoluble fractions
from control thoraces, and head and abdominal extracts at
8 weeks of age, in comparison with 1 week of age (Figure 6I).
However, ubiquitin levels were only partially increased in old
foxo-overexpressing flies in both thoracic and head and abdom-
inal extracts. No substantial differences were instead detected in
the Triton X-100 soluble fractions (data not shown). Similar
results were obtained by 4E-BP CA but not Hsp70 overexpres-
sion in muscles (Figure 6I; Figure S5), indicating that 4E-BPactivity in muscles also confers systemic protection from the
age-related decline in proteostasis. To test whether this effect
is muscle-specific, we overexpressed foxo in the adipose tissue
(abdominal fat body) with the S106GS-Gal4 driver, and analyzed
the deposition of polyubiquitinated proteins in Triton X-100
insoluble fractions from thoraces. Under these conditions, we
seemingly detected no differences (Figure S6), suggesting that,
although other tissues may be involved, muscles may play a
key role in this regulation. Altogether, these observations sug-
gest that FOXO and 4E-BP activity in muscles mitigates the
loss of proteostasis nonautonomously by influencing feeding
behavior, insulin release fromproducing cells, and 4E-BP activity
in other tissues.
DISCUSSION
By using a number of behavioral, genetic, and molecular assays,
we have described a mechanism in the pathogenesis of muscle
aging that is based on the loss of protein homeostasis (proteo-
stasis) and the resulting decrease in muscle strength (Figure 7).
Increased activity of Pten and the transcription factor FOXO is
sufficient to delay this process, while foxo null animals experi-
ence accelerated loss of proteostasis during muscle aging.
Pten and FOXO induce multiple protective responses, including
the expression of folding chaperones and the regulator of protein
translation 4E-BP that has a pivotal role in preserving proteosta-
sis. FOXO and 4E-BP preserve muscle function, at least in part
by sustaining the basal activity of the autophagy/lysosome
system, which removes aggregates of damaged proteins.
However, additional mechanismsmay be involved. For example,
the proteasome system may degrade damaged proteins and
thus avoid their accumulation in aggregates (Rubinsztein,
2006). Thus, perturbation in proteasome assembly and subunit
composition may contribute to muscle aging in response to
FOXO activity. In addition, whereas overexpression of a single
chaperone had limited effects, interventions to effectively limit
the extent of protein damage are likely to delay the decay in
proteostasis by decreasing the workload for the proteasome
and autophagy systems (Tower, 2009).
By comparing the accumulation of polyubiquitinated proteins
in aggregates of aging muscles, retinas, brains, and adipose
tissue, we have found that reduced protein homeostasis is a
general feature of tissue aging that is particularly prominent in
muscles (Figure 1, Figure 6, and Figure S6). The observation
that muscle aging is characterized by loss of proteostasis further
suggests some similarity between muscle aging and neurode-
generative diseases, many of which are characterized by the
accumulation of protein aggregates (Rubinsztein, 2006).
Mechanical, thermal, and oxidative stressors occur during
muscle contraction (Arndt et al., 2010), and therefore muscle
proteins may be particularly susceptible to damage in compar-
ison with other tissues. While our findings refer to the loss of
proteostasis in the context of normal aging, it is likely that a better
understanding of this process will help cure muscle pathologies
associated with aging, as some of the underlying mechanisms of
etiology may be shared. For example, most cases of inclusion
body myositis (IBM) arise over the age of 50 years, defining
aging as a major risk factor for the pathogenesis of this disease.Cell 143, 813–825, November 24, 2010 ª2010 Elsevier Inc. 821
Figure 6. Systemic Proteostasis Is Remotely Controlled by FOXO/4E-BP Signaling in Muscles
(A–F) Aggregates of polyubiquitinated proteins accumulate during aging in the retina (A and D), brain (B and E), and the adipose tissue (C and F) of control flies
(Mhc-Gal4/+), but to a lesser extent in tissues from flies overexpressing foxo in muscles (UAS-foxo/+;Mhc-Gal4/+), as indicated by polyubiquitin (red) and p62/Ref
(2)P (green) stainings. Phalloidin staining (blue) outlines F-actin. Note that Mhc-Gal4 does not drive transgene expression in these tissues (Figure S1). Scale bar is
10 mm.
(G and H) The age-related increase in the cumulative area of protein aggregates is significantly less prominent in tissues from flies overexpressing foxo (G) or
4E-BP CA (H) in muscles in comparison with controls (SEM is indicated with n; *p < 0.05. **p < 0.01, and ***p < 0.001).
(I) Ubiquitin levels (indicative of protein aggregates) are detected in Triton X-100 insoluble fractions from thoraces, and head and abdominal tissues from flies
overexpressing foxo in muscles or control flies at 1 (young, black) and 8 (old, red) weeks of age. Ubiquitin levels are increased in old flies in comparison with young
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Figure 7. FOXO/4E-BP Signaling inMuscles
Controls Proteostasis and Systemic Aging
Muscle aging is characterized by protein damage
and accumulation of cytoplasmic aggregates.
Loss of protein homeostasis (proteostasis) associ-
ates with the progressive decrease in muscle
strength and can affect the life span of the
organism. Pten/FOXO signaling induces multiple
targets including several folding chaperones
and the regulator of protein translation 4E-BP.
FOXO/4E-BP activity regulates muscle proteosta-
sis at least in part via the autophagy/lysosome
pathway of protein degradation, preservesmuscle
function, and extends life span. In addition, FOXO/
4E-BP signaling in muscles decreases feeding
behavior that, similar to fasting, results in reduced
insulin release from producing cells. This in turn
promotes FOXO and 4E-BP activity in other
tissues, preserving proteostasis organism-wide
and mitigating systemic aging.Interestingly, muscle weakness in patients with IBM is character-
ized by the accumulation of protein aggregates (Needham and
Mastaglia, 2008), which we have now described as occurring
in the context of regular muscle aging in Drosophila. Thus,
FOXO may interfere with the pathogenesis of muscle degenera-
tive diseases in addition to muscle aging. Studies in animal
disease models of IBM will be needed to test this hypothesis.
There is an apparent contradiction between our findings and
the data describing the FOXO-dependent induction of muscle
atrophy inmice (Bodine et al., 2001; Sandri et al., 2004), a serious
form of muscle degeneration that results in decreased muscle
strength (Augustin and Partridge, 2009). The observation that
different degrees of FOXO activation can promote stress resis-
tance, or rather cell death (Salih and Brunet, 2008), could explain
why FOXO activity can be protective or rather detrimental during
muscle aging. In particular, while physiologic FOXO activation
can preserve protein homeostasis and muscle function, its
excessive activation may lead to decreased muscle function
due to hyperactivation of the protein turnover pathways. Consis-
tent with this view, the autophagy pathway has also been
involved in both muscle atrophy (Mammucari et al., 2007;
Zhao et al., 2007) and in the preservation of muscle sarcomere
organization (Arndt et al., 2010; Masiero et al., 2009), high-
lighting the importance of fine-tuning the degree of activation
of stress resistance pathways to maintain muscle homeostasis.
In addition, the output of FOXO activity may radically differ in
growing versus preexisting myofibers. In particular, our present
study indicates that FOXO protects preexisting myofibersflies in extracts from both muscles (thoraces) and nonmuscle tissues (heads and abdomens). However, fl
deposition of protein aggregates at 8 weeks of age in both muscles and nonmuscle tissues. Similar results ar
in muscles (I), but not Hsp70 (Figure S5). Quantification of ubiquitin-conjugated proteins normalized to a-tub
See also Figures S1, Figure S5, and Figure S6.
Cell 143, 813–825, Nagainst age-dependent changes in pro-
teostasis while also blunting develop-
mental muscle growth in flies (Demontis
and Perrimon, 2009), as observed in
mammals (Kamei et al., 2004). Thus,deleterious effects of FOXO activation as observed in mamma-
lian muscles may result from the inhibition of the growth of novel
myofibers in postnatal development and adulthood, a process
which is thought to be limited to development in Drosophila
(Grefte et al., 2007).
An interesting observation of our study is that interventions
that decrease muscle aging also extend the life span of the
organism. In particular, our work raises the prospect that the
extent of muscle aging may be a key determinant of systemic
aging (Figure 7). Reduced muscle proteostasis may be detri-
mental per se for life expectancy, presumably due to the involve-
ment of muscles in a number of key physiological functions.
Consistent with this view, overexpression inmuscles of aggrega-
tion-prone human Huntington’s disease proteins is sufficient to
decrease life span (Figure S7). Moreover, FOXO signaling in
muscles regulates proteostasis in other tissues, via the inhibition
of feeding behavior and the decreased release of insulin from
producing cells, which in turn promote 4E-BP activity systemi-
cally. Thus, we propose that FOXO/4E-BP signaling in muscles
regulates life span and remotely controls aging events in other
tissues by bringing about some of the protection associated
with decreased food intake.
In mammals, muscles produce a number of cytokines involved
in the control of systemic metabolism (Nair, 2005; Pedersen and
Febbraio, 2008). For example, interleukin-6 (IL-6) is produced by
muscles and has been proposed to control glucose homeostasis
and feeding behavior through peripheral and brain mechanisms
(Febbraio and Pedersen, 2002; Plata-Salaman, 1998). Thus,ies overexpressing foxo in muscles have reduced
e obtained in response to increased 4E-BP activity
ulin or histone H3 levels is indicated.
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a muscle-based network of systemic aging as observed in flies
may occur in humans.
This study supports the common belief that preservingmuscle
function is beneficial for overall aging (Boyle et al., 2009; Chen
et al., 2005), and the notion that muscles are central tissues
to coordinate organism-wide processes, including aging and
metabolic homeostasis (Nair, 2005). Moreover, the observation
that FOXO signaling in muscles influences aging events in other
tissues suggests that the systemic regulation of aging relies on
tissue-to-tissue communication (Russell and Kahn, 2007), which
may provide the basis for interventions to extend healthy life
span.
EXPERIMENTAL PROCEDURES
Drosophila Strains and Life Span Analysis
Details on fly strains can be found in Extended Experimental Procedures.
For longevity measurement, male flies were collected within 24 hr from
eclosion and reared at standard density (20 flies per vial) on cornmeal/soy
flour/yeast fly food at 25C. Dead flies were counted every other day and
food changed. For each genotype, at least two independent cohorts of flies,
raised at different times from independent crosses, were analyzed. For starva-
tion treatments, flies were kept in normal vials with 1.5% agar as a water
source for the period of time indicated. For all experiments, Mhc-Gal4 females
were mated with male transgenic and syngenic control flies, and the resulting
male offspring analyzed in parallel by comparing transgene expressing
flies with matched controls flies having the same genetic background. For
transgene expression with the Gal4-UAS system, flies were reared at 25C.
Behavioral and Metabolic Assays
Flight ability was scored according to Park et al. (2006), and negative geotaxis
assays were performed as previously described (Rhodenizer et al., 2008). In
brief, flies were gently tapped to the bottom of a plastic vial, and the number
of flies that could climb to the top of the vial after 20 s was scored. Quantifica-
tion of the glucose concentration in the hemolymph, and capillary (CAFE´) and
blue-colored food feeding assays were done as previously described
(Geminard et al., 2009; Xu et al., 2008) and are described in detail in Extended
Experimental Procedures.
Immunostaining, Confocal and Electron Microscopy,
and Image Analysis
For whole-mount immunostaining of the fly tissues, indirect flight muscles, and
peripheral fat body of the abdomen, retinas, and brains were dissected from
male flies and fixed for 30–40 min in PBS with 4% paraformaldehyde and
0.2% Triton X-100. After washing, samples were incubated overnight with
appropriate primary and secondary antibodies. Image analysis was done
with ImageJ and Photoshop. Immuno-gold electron microscopy was done
similar to Nezis et al., (2008). See Extended Experimental Procedures for
further information and a list of the antibodies used.
Quantitative Real-Time RT-PCR
qRT-PCR was done as previously described (Demontis and Perrimon, 2009).
Total RNA was prepared from fly thoraces and qRT-PCR was performed
with the QuantiTect SYBR Green PCR kit (QIAGEN). Alpha-Tubulin 84B was
used as normalization reference. Relative quantification of mRNA levels was
calculated using the comparative CT method.
Statistical Analysis
Statistical analysis was performed with Excel (Microsoft) and p values were
calculated with Student’s t tests and log-rank tests.
Western Blot and Biochemical Analysis of Detergent-Insoluble
Fractions
Western blot and biochemical analysis of detergent-insoluble fractions were
done substantially as previously described (Nezis et al., 2008). In brief,824 Cell 143, 813–825, November 24, 2010 ª2010 Elsevier Inc.dissected flies were homogenized in ice-cold PBS with 1% Triton X-100 and
protease inhibitors, and the resulting unsoluble pellet resuspended in RIPA
buffer with 5% SDS and 8M urea. See Extended Experimental Procedures
for a complete protocol.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
seven figures, and two tables and can be found with this article online at
doi:10.1016/j.cell.2010.10.007.
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